• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤细胞源性和巨噬细胞源性组织蛋白酶B促进乳腺癌的进展和肺转移。

Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer.

作者信息

Vasiljeva Olga, Papazoglou Anna, Krüger Achim, Brodoefel Harald, Korovin Matvey, Deussing Jan, Augustin Nicole, Nielsen Boye S, Almholt Kasper, Bogyo Matthew, Peters Christoph, Reinheckel Thomas

机构信息

Institut für Molekulare Medizin und Zellforschung and Institut für Biometrie und Medizinische Informatik, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.

出版信息

Cancer Res. 2006 May 15;66(10):5242-50. doi: 10.1158/0008-5472.CAN-05-4463.

DOI:10.1158/0008-5472.CAN-05-4463
PMID:16707449
Abstract

Proteolysis in close vicinity of tumor cells is a hallmark of cancer invasion and metastasis. We show here that mouse mammary tumor virus-polyoma middle T antigen (PyMT) transgenic mice deficient for the cysteine protease cathepsin B (CTSB) exhibited a significantly delayed onset and reduced growth rate of mammary cancers compared with wild-type PyMT mice. Lung metastasis volumes were significantly reduced in PyMT;ctsb(+/-), an effect that was not further enhanced in PyMT;ctsb(-/-) mice. Furthermore, lung colonization studies of PyMT cells with different CTSB genotypes injected into congenic wild-type mice and in vitro Matrigel invasion assays confirmed a specific role for tumor-derived CTSB in invasion and metastasis. Interestingly, cell surface labeling of cysteine cathepsins by the active site probe DCG-04 detected up-regulation of cathepsin X on PyMT;ctsb(-/-) cells. Treatment of cells with a neutralizing anti-cathepsin X antibody significantly reduced Matrigel invasion of PyMT;ctsb(-/-) cells but did not affect invasion of PyMT;ctsb(+/+) or PyMT;ctsb(+/-) cells, indicating a compensatory function of cathepsin X in CTSB-deficient tumor cells. Finally, an adoptive transfer model, in which ctsb(+/+), ctsb(+/-), and ctsb(-/-) recipient mice were challenged with PyMT;ctsb(+/+) cells, was used to address the role of stroma-derived CTSB in lung metastasis formation. Notably, ctsb(-/-) mice showed reduced number and volume of lung colonies, and infiltrating macrophages showed a strongly up-regulated expression of CTSB within metastatic cell populations. These results indicate that both cancer cell-derived and stroma cell-derived (i.e., macrophages) CTSB plays an important role in tumor progression and metastasis.

摘要

肿瘤细胞附近的蛋白水解是癌症侵袭和转移的一个标志。我们在此表明,与野生型PyMT小鼠相比,缺乏半胱氨酸蛋白酶组织蛋白酶B(CTSB)的小鼠乳腺肿瘤病毒-多瘤中间T抗原(PyMT)转基因小鼠的乳腺癌发病明显延迟且生长速度降低。PyMT;ctsb(+/-)小鼠的肺转移体积显著减少,在PyMT;ctsb(-/-)小鼠中这一效应并未进一步增强。此外,将不同CTSB基因型的PyMT细胞注射到同基因野生型小鼠中进行肺定植研究以及体外基质胶侵袭试验证实了肿瘤来源的CTSB在侵袭和转移中的特定作用。有趣的是,活性位点探针DCG-04对半胱氨酸组织蛋白酶的细胞表面标记检测到PyMT;ctsb(-/-)细胞上组织蛋白酶X上调。用中和性抗组织蛋白酶X抗体处理细胞可显著降低PyMT;ctsb(-/-)细胞的基质胶侵袭,但不影响PyMT;ctsb(+/+)或PyMT;ctsb(+/-)细胞的侵袭,表明组织蛋白酶X在CTSB缺陷肿瘤细胞中具有补偿功能。最后,采用一种过继转移模型,用PyMT;ctsb(+/+)细胞攻击ctsb(+/+)、ctsb(+/-)和ctsb(-/-)受体小鼠,以探讨基质来源的CTSB在肺转移形成中的作用。值得注意的是,ctsb(-/-)小鼠的肺集落数量和体积减少,浸润的巨噬细胞在转移细胞群体中显示出CTSB的强烈上调表达。这些结果表明,癌细胞来源和基质细胞来源(即巨噬细胞)的CTSB在肿瘤进展和转移中都起着重要作用。

相似文献

1
Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer.肿瘤细胞源性和巨噬细胞源性组织蛋白酶B促进乳腺癌的进展和肺转移。
Cancer Res. 2006 May 15;66(10):5242-50. doi: 10.1158/0008-5472.CAN-05-4463.
2
Transgenic expression of human cathepsin B promotes progression and metastasis of polyoma-middle-T-induced breast cancer in mice.人组织蛋白酶 B 的转基因表达促进多瘤病毒中 T 抗原诱导的乳腺癌在小鼠中的进展和转移。
Oncogene. 2011 Jan 6;30(1):54-64. doi: 10.1038/onc.2010.387. Epub 2010 Sep 6.
3
Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice.组织蛋白酶B缺陷小鼠中肿瘤细胞增殖减少,高级别乳腺癌的发展延迟。
Oncogene. 2008 Jul 10;27(30):4191-9. doi: 10.1038/onc.2008.59. Epub 2008 Mar 17.
4
Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression.过表达人组织蛋白酶 B 在小鼠乳腺癌进展中的细胞类型依赖性致病功能。
Oncogene. 2014 Sep 4;33(36):4474-84. doi: 10.1038/onc.2013.395. Epub 2013 Sep 30.
5
Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice.乳腺癌3共激活因子单倍体失活降低过氧化物酶体增殖物激活受体γ和视黄酸X受体对细胞增殖的抑制作用,并加速多瘤病毒中间T抗原诱导的小鼠乳腺肿瘤发生。
Cancer Res. 2004 Oct 1;64(19):7169-77. doi: 10.1158/0008-5472.CAN-04-1176.
6
MEKK1 controls matrix degradation and tumor cell dissemination during metastasis of polyoma middle-T driven mammary cancer.MEKK1在多瘤病毒中T抗原驱动的乳腺癌转移过程中控制基质降解和肿瘤细胞播散。
Oncogene. 2006 Aug 17;25(36):4998-5010. doi: 10.1038/sj.onc.1209507. Epub 2006 Mar 27.
7
Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice.纤溶酶原缺陷小鼠中多瘤病毒中T抗原诱导的乳腺癌转移减少
Oncogene. 1998 Jun 18;16(24):3097-104. doi: 10.1038/sj.onc.1201869.
8
MT1-MMP is required for efficient tumor dissemination in experimental metastatic disease.MT1-MMP是实验性转移性疾病中肿瘤有效播散所必需的。
Oncogene. 2008 May 22;27(23):3274-81. doi: 10.1038/sj.onc.1210982. Epub 2007 Dec 10.
9
Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice.联合组织蛋白酶 B 和组织蛋白酶 Z 缺失对小鼠乳腺癌进展和转移的协同抗肿瘤作用。
Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2497-502. doi: 10.1073/pnas.0907240107. Epub 2010 Jan 21.
10
Dual stromelysin-3 function during natural mouse mammary tumor virus-ras tumor progression.基质溶解素-3在自然小鼠乳腺肿瘤病毒-ras肿瘤进展过程中的双重作用。
Cancer Res. 2003 Sep 15;63(18):5844-9.

引用本文的文献

1
Therapeutic targeting of tumour-associated macrophage receptors.肿瘤相关巨噬细胞受体的治疗靶向作用
Immunother Adv. 2025 Mar 11;5(1):ltaf009. doi: 10.1093/immadv/ltaf009. eCollection 2025.
2
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial.嵌合抗原受体巨噬细胞疗法治疗HER2过表达晚期实体瘤:一项1期试验
Nat Med. 2025 Apr;31(4):1171-1182. doi: 10.1038/s41591-025-03495-z. Epub 2025 Feb 7.
3
Crosstalk Between Macrophages and Breast Cancer Cells: Networking Within Tumors.巨噬细胞与乳腺癌细胞的串扰:肿瘤内的网络联系。
Results Probl Cell Differ. 2024;74:213-238. doi: 10.1007/978-3-031-65944-7_8.
4
MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer.MYC 和 KRAS 合作:癌症治疗机遇中的历史挑战。
Signal Transduct Target Ther. 2024 Aug 21;9(1):205. doi: 10.1038/s41392-024-01907-z.
5
Enzyme-Activatable Chemokine Conjugates for In Vivo Targeting of Tumor-Associated Macrophages.用于体内靶向肿瘤相关巨噬细胞的酶激活趋化因子缀合物
Angew Chem Weinheim Bergstr Ger. 2022 Oct 10;134(41):e202207508. doi: 10.1002/ange.202207508. Epub 2022 Sep 5.
6
Defining and targeting macrophage heterogeneity in the mammary gland and breast cancer.定义和靶向乳腺和乳腺癌中的巨噬细胞异质性。
Cancer Med. 2024 Feb;13(3):e7053. doi: 10.1002/cam4.7053.
7
Phenotypic Heterogeneity, Bidirectionality, Universal Cues, Plasticity, Mechanics, and the Tumor Microenvironment Drive Cancer Metastasis.表型异质性、双向性、普遍线索、可塑性、力学和肿瘤微环境推动癌症转移。
Biomolecules. 2024 Feb 3;14(2):184. doi: 10.3390/biom14020184.
8
Isolating Primary Tumor Cells from the MMTV-PyMT Mouse Model and Their Use in Developing an Orthotopic Mouse Model of Breast Cancer.从 MMTV-PyMT 小鼠模型中分离原代肿瘤细胞及其在建立乳腺癌原位小鼠模型中的应用。
Methods Mol Biol. 2024;2773:59-65. doi: 10.1007/978-1-0716-3714-2_6.
9
The Role of Cysteine Protease Cathepsins B, H, C, and X/Z in Neurodegenerative Diseases and Cancer.半胱氨酸蛋白酶 Cathepsins B、H、C 和 X/Z 在神经退行性疾病和癌症中的作用。
Int J Mol Sci. 2023 Oct 26;24(21):15613. doi: 10.3390/ijms242115613.
10
A New Cathepsin D Targeting Drug Delivery System Based on Immunoliposomes Functionalized with Lipidated Pepstatin A.一种基于用脂化胃蛋白酶抑制剂A功能化的免疫脂质体的新型组织蛋白酶D靶向给药系统。
Pharmaceutics. 2023 Oct 14;15(10):2464. doi: 10.3390/pharmaceutics15102464.